Mode
Text Size
Log in / Sign up
N/A N=54 Treatment

A Retrospective Analysis of the Effects of Low Level Laser Therapy on Toenail Onychomycosis

Onychomycosis

Enrolled (actual)
54
Serious AEs
0.0%
Results posted
Jul 2016
Primary outcome: Primary: Percent (%) of Toenails Attaining 3 Millimeters (mm) or More of Clear Nail Growth — 67 Percent of Toenails

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Erchonia LUNULA (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Erchonia Corporation
Primary completion
Oct 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Percent (%) of Toenails Attaining 3 Millimeters (mm) or More of Clear Nail Growth
67
SECONDARY
Change in Millimeters (mm) of Clear Nail Bed
5.18 <0.0001 sig

Summary

The purpose of this study is to determine whether low level laser therapy (LLLT) using the Erchonia LUNULA device is effective in increasing clear nail in toenails with onychomycosis.

Eligibility Criteria

Inclusion Criteria

  • Great toenail presents with clearly visually identifiable and photographically documentable onychomycosis of the great toenail, or no visible onychomycosis (1 great toenail)
  • Onychomycosis has been identified as due to bacterial/fungal infection classified by the investigator as onychomycosis, with the nail presenting positive on visual inspection for somewhat thickened nail plate with a cloudy appearance and some discoloration (white to yellow to brown)
  • Onychomycosis etiology has been confirmed through positive fungal potassium hydroxide preparation (KOH) testing results

Exclusion Criteria

  • Spikes of disease extending to nail matrix in the great toenail
  • Infection involving lunula of the great toenail, e.g. genetic nail disorders, primentary disorders
  • Great toenail has less than 2mm clear (unaffected) nail plate length beyond the proximal fold
  • Dermatophytoma or "yellow spike/streak" (defined as thick masses of fungal hyphae and necrotic keratin between the nail plate and nail bed) on the great toenail
  • Onychogryphosis
  • Proximal subungual onychomycosis
  • White superficial onychomycosis
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02588599). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search